The biotechnology industry in Michigan showcases a commitment to innovation and health advancements. Companies engage in various sectors, producing diagnostics, vaccines, therapeutics, and drug development services. With robust research capabilities, these businesses focus on both pharmaceuticals and independent biotech solutions. Recent trends indicate an increasing integration of artificial intelligence and data analytics into research processes, improving efficiency and results. The state's research institutions foster partnerships with industry players, paving the way for novel health solutions. As health needs evolve, biotech companies are shifting towards more personalized medicine, emphasizing the significance of tailored treatment approaches.


This listing highlights 25 notable biotechnology companies in Michigan, mainly concentrated in Ann Arbor and Kalamazoo. Companies range from small startups with fewer than ten employees to significant corporate entities with hundreds of staff. Many were founded in the early 2000s, focusing on specialized technologies such as cell separation, molecular diagnostics, and vaccine development. This diverse array of businesses underscores Michigan’s prominence as a hub for biotechnology innovation and research.


Read on to discover the top biotechnology companies in Michigan.


Top 25 Biotechnology Companies in Michigan


1. Indena

  • Website: indena.com
  • Ownership type: Corporate
  • Headquarters: Milan, Michigan, United States (USA)
  • Employee distribution: Italy 76%, France 17%, India 5%, Other 2%
  • Latest funding: November 2019
  • Founded year: 1921
  • Headcount: 501-1000
  • LinkedIn: indena

Indena, founded in 1921 and headquartered in Milan, Italy, is a corporate entity that specializes in the manufacture of pharmaceutical and nutraceutical products derived from botanical sources. The company operates globally, providing high-quality health solutions to various businesses in the pharmaceutical and nutraceutical sectors. Indena is known for its commitment to sustainability and innovation, managing a robust supply chain that emphasizes the responsible sourcing of botanical materials. Their research and development efforts focus on phytochemical engineering, which allows them to create advanced products like Indena Phytosome™ Technology. This technology enhances the bioavailability of natural compounds, making them more effective in supporting human health. With a workforce of around 494 employees, Indena maintains a significant presence in the industry, particularly in Italy, France, and India, and is actively involved in various international markets.


2. BlueWillow Biologics, Inc.

  • Website: bluewillow.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Latest funding: Other (Grant), September 2018
  • Founded year: 2000
  • Headcount: 11-50
  • LinkedIn: nanobio-corporation

BlueWillow Biologics, Inc. is a biotechnology firm based in Ann Arbor, Michigan, founded in 2000. The company specializes in the development of intranasal vaccines and adjuvant technology, aiming to enhance public health through innovative vaccine delivery systems. Their proprietary oil-in-water emulsion platform has shown safety and efficacy in human clinical trials, with over 400 individuals dosed to date. BlueWillow's technology is designed to elicit robust immune responses, making it suitable for a wide range of vaccine candidates. The company has been involved in various clinical trials, including a Phase 1 trial for an intranasal anthrax vaccine, which has yielded positive interim results. Their focus on addressing infectious diseases through advanced vaccine solutions positions them as a relevant player in the biotechnology industry.


3. Proteos

  • Website: proteos.com
  • Ownership type: Corporate
  • Headquarters: Kalamazoo, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: January 2025
  • Founded year: 2003
  • Headcount: 11-50
  • LinkedIn: proteos

Proteos is a biotechnology company based in Kalamazoo, Michigan, founded in 2003. The company specializes in recombinant protein production services, offering a range of solutions including protein expression, purification, and assay services. Proteos primarily serves clients in the biotechnology and pharmaceutical sectors, providing tailored solutions to meet specific project needs. Their scientific team boasts decades of combined experience, allowing them to navigate the complexities of protein production effectively. As an independent, employee-owned organization, Proteos emphasizes ethical business practices and actively engages in charitable initiatives. They are recognized for their commitment to high-quality deliverables and have established a loyal client base, with many clients returning for multiple projects. Proteos also collaborates with organizations like The Michael J. Fox Foundation to support research initiatives, further solidifying their role in the biotechnology industry.


4. Upkara

  • Website: upkara.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Latest funding: Series A, $9.2M, April 2023
  • Founded year: 2017
  • Headcount: 11-50
  • LinkedIn: upkara

Upkara, now operating under the name Ambient Biosciences, is a biotechnology firm based in Ann Arbor, Michigan. Founded in 2017, the company specializes in innovative biomolecule stabilization technology. Their primary mission is to eliminate the reliance on cold chain logistics for temperature-sensitive reagents, which is crucial for enhancing global health equity. Ambient Biosciences has developed a patented process that stabilizes biomolecules at room temperature, significantly extending their shelf life and maintaining their activity. This technology is particularly beneficial for the biotechnology and pharmaceutical sectors, where the stability of reagents is paramount. The company has recently secured $9.15 million in Series A funding, indicating strong investor confidence in their approach and potential impact in the industry.


5. Akadeum Life Sciences, Inc.

  • Website: akadeum.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series B, May 2023
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn: akadeum-life-sciences-inc-

Akadeum Life Sciences, Inc., founded in 2014 and based in Ann Arbor, Michigan, is a biotechnology firm that focuses on cell separation technology. The company has developed the Alerion™ Microbubble Cell Separation System, which utilizes microbubble technology to enhance the efficiency and effectiveness of cell isolation. Their product offerings include various T cell isolation kits and purification products, catering to researchers and companies in the life sciences sector. Akadeum's solutions are designed to improve cell health and viability, addressing critical needs in cell therapy and immunology. The company is actively involved in advancing methodologies that support the development of therapies, particularly in the context of CAR T cell therapy. Their commitment to innovation is evident in their continuous product development and the introduction of new technologies to the market.


6. TSRL, Inc

  • Website: tsrlinc.com
  • Ownership type: Private
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 1986
  • Headcount: 11-50
  • LinkedIn: tsrl-inc

TSRL, Inc., based in Ann Arbor, Michigan, is a biotechnology company founded in 1986. The firm specializes in the development of therapeutics aimed at combating infectious diseases. TSRL operates as a preclinical accelerator, providing essential infrastructure and expertise to advance drug development projects. Their focus includes innovative delivery systems, such as microneedle patches, which aim to improve the administration of therapeutics. The company has a robust pipeline that includes projects targeting influenza antivirals, cell-penetrating peptides, and multi-drug resistant bacterial infections. TSRL has successfully collaborated with various academic and industry partners, leveraging non-dilutive funding opportunities to support their research initiatives. Their recent achievements include securing significant grants from the National Institutes of Health (NIH) to further their development of novel therapeutics, showcasing their active role in the biotechnology sector.


7. ONL Therapeutics

  • Website: onltherapeutics.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series D, $65.0M, September 2024
  • Founded year: 2011
  • Headcount: 1-10
  • LinkedIn: onl-therapeutics

ONL Therapeutics, based in Ann Arbor, Michigan, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for retinal diseases. Founded in 2011, the company is focused on addressing critical issues in vision loss through its lead product, ONL1204. This first-in-class small peptide is designed to inhibit the Fas receptor, which plays a crucial role in cell death and inflammation in retinal cells. ONL Therapeutics targets conditions such as geographic atrophy associated with age-related macular degeneration and open-angle glaucoma, aiming to improve patient outcomes and preserve vision. The company is actively conducting clinical trials to evaluate the safety and efficacy of ONL1204, and it has recently secured $65 million in Series D funding, underscoring its commitment to advancing its pipeline and addressing significant medical needs in ophthalmology.


8. Strata Oncology

  • Website: strataoncology.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series C, $90.0M, July 2021
  • Founded year: 2016
  • Headcount: 51-200
  • LinkedIn: strata-oncology

Strata Oncology, founded in 2016 and based in Ann Arbor, Michigan, is a precision oncology company dedicated to improving cancer treatment through advanced biomarker solutions. The company specializes in developing diagnostic tools that help healthcare providers make informed decisions about cancer therapies. Their flagship products include the Strata Select, a molecular profiling solution for patients with advanced cancer, and the Immunotherapy Response Score, which predicts patient responses to immunotherapy. Strata Oncology's approach combines molecular profiling with real-world data and clinical trial platforms to optimize treatment strategies. The company has attracted significant venture capital, securing $90 million in its latest funding round in July 2021. This financial backing supports their mission to enhance treatment outcomes for cancer patients and solidifies their position in the biotechnology industry.


9. Cayman Chemical

  • Website: caymanchem.com
  • Ownership type: Private
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 99%
  • Latest funding: Other (Grant), $1.5M, April 2019
  • Founded year: 1980
  • Headcount: 201-500
  • LinkedIn: cayman-chemical

Cayman Chemical, founded in 1980 and based in Ann Arbor, Michigan, is a biotechnology company dedicated to supporting scientific research. The company specializes in the production and supply of high-quality assay kits, antibodies, biochemicals, and proteins, which are essential for researchers in the life sciences and pharmaceutical sectors. Cayman Chemical also offers contract research services, further enhancing their role in facilitating scientific studies. With a workforce of approximately 287 employees, the company primarily serves clients in the United States, reflecting a strong domestic focus. Their commitment to quality and innovation has made them a reliable partner for researchers seeking to advance their work. In 2019, Cayman Chemical received a grant of $1.5 million, indicating continued investment in their capabilities and services.


10. Northern Biomedical Research


Northern Biomedical Research, based in Norton Shores, Michigan, is a private biomedical research organization founded in 1993. The company specializes in non-clinical research, focusing on drug delivery systems across various therapeutic areas, including neurology, ophthalmology, cardiology, and orthopedics. They cater to pharmaceutical and biotechnology firms, providing critical testing and validation services for new therapies. Their mission emphasizes the importance of ensuring drug safety and efficacy prior to clinical trials. With a robust facility that includes advanced imaging equipment and a team of experienced professionals, Northern Biomedical Research is equipped to conduct comprehensive studies that support the development of innovative medical solutions. Their adherence to strict regulatory standards and ethical practices in animal research underscores their commitment to responsible science. The company continues to expand its service offerings to meet the evolving needs of the biotechnology industry.


11. PharmOptima

  • Website: pharmoptima.com
  • Ownership type: Corporate
  • Headquarters: Portage, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: April 2017
  • Founded year: 2003
  • Headcount: 11-50
  • LinkedIn: pharmoptima

PharmOptima, founded in 2003 and based in Portage, Michigan, is a contract research organization (CRO) that provides specialized services to the biotechnology and pharmaceutical industries. With a team of experienced scientists, PharmOptima focuses on drug discovery and development, offering a range of services including DMPK/ADME studies, ocular efficacy assessments, and bioanalytical services. Their expertise extends to custom assay development and in vivo pharmacokinetic studies, which are crucial for clients looking to advance their drug candidates through the development pipeline. PharmOptima's commitment to delivering high-quality data in a timely manner supports their clients in navigating the complexities of drug development. They are also a member of Genesis Drug Discovery & Development (GD3), enhancing their capabilities in managing clinical trials and supporting drug discovery programs from initial target discovery to IND filing.


12. Northern Biomolecular Services

  • Website: nbslab.com
  • Ownership type: Private
  • Headquarters: Kalamazoo, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2019
  • Headcount: 1-10
  • LinkedIn: northern-biomolecular-services

Northern Biomolecular Services (NBS) is a contract research organization based in Kalamazoo, Michigan, established in 2019. The company specializes in advanced molecular biological techniques, focusing on the evaluation of biodistribution, persistence, and gene expression of cell and gene therapy products. NBS offers a range of services, including custom assay development, nucleic acid extraction, and comprehensive biodistribution analysis. Their expertise is particularly relevant for clients in the biotechnology and pharmaceutical sectors, where high-quality data and regulatory compliance are critical. The team at NBS boasts over 50 years of combined experience in contract research, with a strong emphasis on good laboratory practices (GLP). They have successfully managed numerous studies, contributing to the development of innovative therapies. NBS collaborates with industry leaders to implement state-of-the-art instrumentation, ensuring that they remain at the forefront of molecular biology research.


13. Michigan Diagnostics LLC


Michigan Diagnostics LLC, based in Royal Oak, Michigan, is a private biotechnology firm founded in 1998 by Dr. Brij P. Giri. The company specializes in the development and manufacturing of diagnostic reagents and kits tailored for both research and clinical applications. With a focus on high-quality products at lower costs, Michigan Diagnostics serves a variety of customers in the biotechnology and healthcare sectors. Their product offerings include chemiluminescent substrates for enzyme detection, such as horseradish peroxidase (HRP) and alkaline phosphatase (AP), which are widely used in immunoassays and other diagnostic tests. The company has also established strategic partnerships to enhance its product development and manufacturing capabilities. All products are subject to rigorous quality control and have received various regulatory approvals, ensuring their reliability in laboratory settings.


14. Genemarkers


Genemarkers, founded in 2008 and based in Kalamazoo, Michigan, is a private research and development company that specializes in clinical testing and research services. With a team of around 30 employees, Genemarkers provides essential services in COVID-19 testing, clinical trial support, and research in personal care and nutrition. Their clientele includes businesses and organizations within the healthcare and biotechnology sectors, seeking reliable testing and research solutions to enhance product safety and efficacy. The company has positioned itself as a resource for organizations looking to navigate the complexities of clinical testing and product development, particularly in the wake of the COVID-19 pandemic. Their work in pharmacogenomics and gene expression panels further illustrates their commitment to advancing biotechnology applications in health and wellness.


15. Innovative Research

  • Website: innov-research.com
  • Ownership type: Private
  • Headquarters: Novi, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 1998
  • Headcount: 11-50
  • LinkedIn: innov-research

Innovative Research, based in Novi, Michigan, is a private biotechnology company founded in 1998. The firm specializes in supplying high-quality biological reagents and materials tailored for research applications. Their product range includes human and animal biologicals, proteins, and antibodies, which are essential for various research endeavors in the biotechnology and life sciences sectors. The company prides itself on reliability and consistency, ensuring that their products meet the specific needs of researchers. With a focus on customer satisfaction, Innovative Research maintains a robust inventory, allowing for same-day shipping on many products. Their extensive experience is reflected in thousands of published references, showcasing their contributions to scientific research. They also offer specialized products, such as single donor mouse biologicals and a comprehensive cancer and disease-state bio repository, further demonstrating their active role in advancing research.


16. Ad Infinitum

  • Website: aicryo.com
  • Ownership type: Private
  • Headquarters: Detroit, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2015
  • Headcount: 1-10
  • LinkedIn: aicryo

Ad Infinitum, known through its website aicryo.com, is a biotechnology firm based in Detroit, Michigan, founded in 2015. The company specializes in cryopreservation solutions tailored for the life sciences sector. Their flagship products, CryoProtectPure and CytoShieldPure, are designed to improve cell viability during the critical processes of freezing and thawing. These products are particularly beneficial for stem cell and cord blood applications, addressing the needs of researchers and organizations that rely on effective cell preservation methods. Ad Infinitum operates from the Michigan Life Science and Innovation Center, indicating a commitment to innovation within the biotechnology space. The company has not reported any funding, suggesting a self-sustained operational model or early-stage development. Their focus on DMSO-free and serum-free solutions highlights a trend towards safer and more effective cryopreservation methods, making them a relevant player in the biotechnology industry.


17. GenePath Diagnostics

  • Website: genepathdx.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: India 83%, United States (USA) 9%, Canada 4%, Other 4%
  • Latest funding: January 2020
  • Founded year: 2012
  • Headcount: 51-200
  • LinkedIn: genepath-dx-causeway-healthcare-pvt-ltd-

GenePath Diagnostics, founded in 2012 and based in Ann Arbor, Michigan, is a company dedicated to providing advanced diagnostic solutions. They specialize in molecular diagnostics and genomic testing, offering a variety of products and services aimed at healthcare providers and research institutions. Their focus areas include infectious diseases, oncology, and genetic disorders. GenePath operates laboratories in both India and the United States, enhancing their ability to deliver high-quality testing solutions. The company has tested nearly 200,000 clinical and research samples at their state-of-the-art laboratory in Pune, India. They also manufacture custom reagents for the research market in the U.S. and have expanded their reach to multiple countries, including Europe, Africa, and the Middle East. GenePath's commitment to improving human life through innovative diagnostic solutions underscores their role in the biotechnology industry.


18. Arbor Assays

  • Website: arborassays.com
  • Ownership type: Private
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2007
  • Headcount: 11-50
  • LinkedIn: arbor-assays

Arbor Assays, founded in 2007 and based in Ann Arbor, Michigan, is a private biotechnology company dedicated to providing high-quality assay testing kits and related products for life sciences research. The company specializes in the development of DetectX® Assay Kits and AbX® Antibodies, which cater to the needs of researchers and laboratories seeking reliable tools for biological analysis. Arbor Assays emphasizes custom assay services, allowing them to tailor solutions to meet specific research requirements. Their commitment to quality is evident as all products are developed in-house, ensuring control over the manufacturing process. The company also offers expert support, assisting clients in utilizing their products effectively in research settings. With over 2,000 citations in peer-reviewed manuscripts, Arbor Assays has made a significant impact in the field of biological research, demonstrating their relevance and contribution to the biotechnology industry.


19. Enumera Molecular

  • Website: enumeramolecular.com
  • Ownership type: Venture Capital
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: Series A, $12.5M, May 2022
  • Founded year: 2022
  • Headcount: 11-50
  • LinkedIn: enumera-molecular

Enumera Molecular, founded in 2022 and based in Ann Arbor, Michigan, is a clinical diagnostics company specializing in molecular testing solutions. The company has developed the EnumeraPlex™ platform, which facilitates liquid biopsy and high-dimensional assays. This platform is designed to simplify complex lab workflows, reduce operational costs, and enhance patient care through innovative technology. With a team of experienced genomic scientists and lab professionals, Enumera aims to democratize access to molecular diagnostics across various clinical applications, including oncology, reproductive health, and infectious disease testing. The company has successfully raised $12.5 million in Series A funding, reflecting strong investor interest in its mission to transform clinical molecular testing.


20. Genomenon, Inc

  • Website: genomenon.com
  • Ownership type: Private Equity
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 50%, Bosnia and Herzegovina 48%, United Kingdom (UK) 2%
  • Latest funding: $5.5M, May 2024
  • Founded year: 2014
  • Headcount: 51-200
  • LinkedIn: genomenon

Genomenon, Inc. is a biotechnology firm based in Ann Arbor, Michigan, founded in 2014. The company specializes in genomic data interpretation and clinical diagnostics, offering innovative software solutions and clinical services aimed at enhancing patient diagnosis and drug development. Their flagship product, the Mastermind Genomic Intelligence Platform, utilizes artificial intelligence to provide insights into genomic data, facilitating the interpretation of variants for clinical applications. Genomenon also maintains a comprehensive database of curated genomic information, which is essential for healthcare providers and pharmaceutical companies. Recently, the company secured funding of approximately $5.46 million in May 2024, reflecting its growth potential and the increasing demand for genomic insights in the healthcare sector.


21. Incucyte Live-Cell Analysis Systems

  • Website: essenbioscience.com
  • Ownership type: Corporate
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Latest funding: $320.0M, March 2017
  • Founded year: 1999
  • Headcount: 51-200
  • LinkedIn: essen-bioscience

Incucyte Live-Cell Analysis Systems, a subsidiary of Essen BioScience, is based in Ann Arbor, Michigan. Founded in 1999, the company focuses on providing innovative live-cell imaging and analysis solutions to researchers in both academia and industry. Their flagship product, the IncuCyte® System, enables real-time monitoring of cellular processes, which is essential for studies in oncology, immunology, and other critical areas of life sciences. The technology allows scientists to observe and analyze cell behavior over time, facilitating a deeper understanding of cellular responses to various treatments. With a strong emphasis on advancing research methodologies, Incucyte has contributed to over 9,000 publications, showcasing the widespread adoption of their systems in scientific studies. The company secured $320 million in funding in 2017, underscoring its potential for growth and innovation in the biotechnology sector.


22. Daicel Arbor Biosciences

  • Website: arborbiosci.com
  • Ownership type: Corporate
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: January 2019
  • Founded year: 2006
  • Headcount: 11-50
  • LinkedIn: arbor-biosciences

Daicel Arbor Biosciences, founded in 2006 and based in Ann Arbor, Michigan, is a biotechnology company dedicated to advancing genomics and proteomics research. With a team of experts, the company provides a range of products and services tailored to the needs of researchers in the life sciences. Their offerings include targeted next-generation sequencing (NGS) kits, cytogenetics probes, and bioinformatics services. These products are designed to facilitate complex research applications, including human health, environmental DNA, and protein engineering. Daicel Arbor's commitment to quality is evident in their in-house manufacturing processes, ensuring reliable performance and consistent results. The company has not reported any recent funding, indicating a stable operational model focused on serving the scientific community.


23. DNA Software Inc.

  • Website: dnasoftware.com
  • Ownership type: Private
  • Headquarters: Plymouth, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: $16.0M, January 2002
  • Founded year: 2000
  • Headcount: 11-50
  • LinkedIn: dna-software%e2%84%a2

DNA Software Inc., based in Plymouth, Michigan, is a biotechnology firm founded in 2000. The company specializes in polymerase chain reaction (PCR) assay design and analysis, offering a suite of software tools and PCR kits aimed at enhancing the efficiency and specificity of testing processes. Their product lineup includes advanced software like PanelPlex™ for multiplex PCR design, Visual OMP™ for simulating assay artifacts, and ThermoSleuth™ for detecting hybridization issues. DNA Software serves a variety of clients, including academic institutions, biotechnology companies, and government agencies, reflecting their significant involvement in the life sciences sector. The company has a history of collaboration with regulatory bodies, such as the CDC and USDA, which underscores their commitment to supporting public health initiatives through innovative assay design. With a dedicated team and a focus on solving complex PCR challenges, DNA Software continues to contribute to advancements in biotechnology.


24. A2-Ai

  • Website: a2-ai.com
  • Ownership type: Private
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2023
  • Headcount: 11-50
  • LinkedIn: a2-ai

A2-Ai, founded in 2023 and based in Ann Arbor, Michigan, is a consulting firm dedicated to providing specialized services in the pharmaceutical and biotechnology sectors. The company focuses on drug development, clinical pharmacology, and pharmacometrics, assisting clients in optimizing their drug development processes and navigating complex regulatory landscapes. A2-Ai's clientele primarily consists of businesses in the pharmaceutical industry looking to enhance their research and development efforts. The firm employs a team of seasoned experts with decades of combined experience, ensuring that clients receive high-quality, customized support tailored to their specific needs. A2-Ai is particularly involved in initiatives like FDA Project Optimus, which aims to improve dose-finding and optimization strategies in oncology, showcasing their commitment to advancing industry standards and practices.


25. MI Bioresearch - A Covance Company

  • Website: mibioresearch.com
  • Ownership type: Private
  • Headquarters: Ann Arbor, Michigan, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2003
  • Headcount: 51-200
  • LinkedIn: mi-bioresearch

MI Bioresearch, a subsidiary of Labcorp, is based in Ann Arbor, Michigan, and was founded in 2003. The company specializes in laboratory services that support drug development and diagnostic testing. They cater to a variety of clients, including biopharma companies, healthcare providers, and individual patients. MI Bioresearch offers a range of services, including nonclinical research and central laboratory services, which are vital for the advancement of new therapies and medical solutions. Their expertise in genetic testing and clinical trial support positions them as a valuable player in the biotechnology field, contributing to the development of innovative health solutions. With a workforce of around 55 employees, MI Bioresearch operates primarily within the United States, focusing on delivering reliable and scientifically rigorous services to enhance health management and drug development processes.



Biotechnology Insights: Key Companies in Michigan


CompanyHeadquarterSizeFoundedOwnership
IndenaMilan, Michigan, United States (USA)501-10001921Corporate
BlueWillow Biologics, Inc.Ann Arbor, Michigan, United States (USA)11-502000Venture Capital
ProteosKalamazoo, Michigan, United States (USA)11-502003Corporate
UpkaraAnn Arbor, Michigan, United States (USA)11-502017Venture Capital
Akadeum Life Sciences, Inc.Ann Arbor, Michigan, United States (USA)11-502014Venture Capital
TSRL, IncAnn Arbor, Michigan, United States (USA)11-501986Private
ONL TherapeuticsAnn Arbor, Michigan, United States (USA)1-102011Venture Capital
Strata OncologyAnn Arbor, Michigan, United States (USA)51-2002016Venture Capital
Cayman ChemicalAnn Arbor, Michigan, United States (USA)201-5001980Private
Northern Biomedical ResearchNorton Shores, Michigan, United States (USA)201-5001993Private
PharmOptimaPortage, Michigan, United States (USA)11-502003Corporate
Northern Biomolecular ServicesKalamazoo, Michigan, United States (USA)1-102019Private
Michigan Diagnostics LLCRoyal Oak, Michigan, United States (USA)11-501998Private
GenemarkersKalamazoo, Michigan, United States (USA)11-502008Private
Innovative ResearchNovi, Michigan, United States (USA)11-501998Private
Ad InfinitumDetroit, Michigan, United States (USA)1-102015Private
GenePath DiagnosticsAnn Arbor, Michigan, United States (USA)51-2002012Venture Capital
Arbor AssaysAnn Arbor, Michigan, United States (USA)11-502007Private
Enumera MolecularAnn Arbor, Michigan, United States (USA)11-502022Venture Capital
Genomenon, IncAnn Arbor, Michigan, United States (USA)51-2002014Private Equity
Incucyte Live-Cell Analysis SystemsAnn Arbor, Michigan, United States (USA)51-2001999Corporate
Daicel Arbor BiosciencesAnn Arbor, Michigan, United States (USA)11-502006Corporate
DNA Software Inc.Plymouth, Michigan, United States (USA)11-502000Private
A2-AiAnn Arbor, Michigan, United States (USA)11-502023Private
MI Bioresearch - A Covance CompanyAnn Arbor, Michigan, United States (USA)51-2002003Private


Want to Find More Biotechnology Companies?

If you want to find more companies that provide vaccines, diagnostics, and therapeutic solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!